AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Robert S. O'Shea; Perica Davitkov; Cynthia W. Ko; Anita Rajasekhar; Grace L. Su; Shahnaz Sultan; Alina M. Allen; Yngve Falck-Ytter

doi:10.1053/j.gastro.2021.08.015

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Robert S. O'Shea, Perica Davitkov, Cynthia W. Ko, Anita Rajasekhar, Grace L. Su, Shahnaz Sultan, Alina M. Allen, Yngve Falck-Ytter

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Original language	English (US)
Pages (from-to)	1615-1627.e1
Journal	Gastroenterology
Volume	161
Issue number	5
DOIs	https://doi.org/10.1053/j.gastro.2021.08.015
State	Published - Nov 2021

Bibliographical note

Funding Information:
Members of the Guideline Panel and TR Panel were selected by the AGA Governing Board and Chair of the Clinical Guidelines Committee with careful consideration of conflict of interest. The Guideline Panel included gastroenterologists and hepatologists, Grading of Recommendations Assessment, Development and Evaluation methodologists, and a hematologist. Development of this guideline and the accompanying TR was fully funded by the AGA Institute without additional outside funding. The TR and guideline underwent independent peer review and a 30-day open public comment period. A patient was also asked to review this guideline and provide feedback. Panel members disclosed all potential conflicts of interest according to the AGA Institute policy. These disclosure statements are maintained at the AGA Institute headquarters in Bethesda, Maryland. No Guideline Panel member was excused from participation in the process owing to disqualifying conflict.

PubMed: MeSH publication types

Journal Article
Meta-Analysis
Practice Guideline
Systematic Review

Publisher link

10.1053/j.gastro.2021.08.015

Find It

Find It at U of M Libraries

Cite this

@article{86244763a6ff4bfdafe7226bebdcdc2b,

title = "AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis",

author = "O'Shea, {Robert S.} and Perica Davitkov and Ko, {Cynthia W.} and Anita Rajasekhar and Su, {Grace L.} and Shahnaz Sultan and Allen, {Alina M.} and Yngve Falck-Ytter",

note = "Funding Information: Members of the Guideline Panel and TR Panel were selected by the AGA Governing Board and Chair of the Clinical Guidelines Committee with careful consideration of conflict of interest. The Guideline Panel included gastroenterologists and hepatologists, Grading of Recommendations Assessment, Development and Evaluation methodologists, and a hematologist. Development of this guideline and the accompanying TR was fully funded by the AGA Institute without additional outside funding. The TR and guideline underwent independent peer review and a 30-day open public comment period. A patient was also asked to review this guideline and provide feedback. Panel members disclosed all potential conflicts of interest according to the AGA Institute policy. These disclosure statements are maintained at the AGA Institute headquarters in Bethesda, Maryland. No Guideline Panel member was excused from participation in the process owing to disqualifying conflict. ",

year = "2021",

month = nov,

doi = "10.1053/j.gastro.2021.08.015",

language = "English (US)",

volume = "161",

pages = "1615--1627.e1",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders Ltd",

number = "5",

}

TY - JOUR

T1 - AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

AU - O'Shea, Robert S.

AU - Davitkov, Perica

AU - Ko, Cynthia W.

AU - Rajasekhar, Anita

AU - Su, Grace L.

AU - Sultan, Shahnaz

AU - Allen, Alina M.

AU - Falck-Ytter, Yngve

N1 - Funding Information: Members of the Guideline Panel and TR Panel were selected by the AGA Governing Board and Chair of the Clinical Guidelines Committee with careful consideration of conflict of interest. The Guideline Panel included gastroenterologists and hepatologists, Grading of Recommendations Assessment, Development and Evaluation methodologists, and a hematologist. Development of this guideline and the accompanying TR was fully funded by the AGA Institute without additional outside funding. The TR and guideline underwent independent peer review and a 30-day open public comment period. A patient was also asked to review this guideline and provide feedback. Panel members disclosed all potential conflicts of interest according to the AGA Institute policy. These disclosure statements are maintained at the AGA Institute headquarters in Bethesda, Maryland. No Guideline Panel member was excused from participation in the process owing to disqualifying conflict.

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85115745539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85115745539&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2021.08.015

DO - 10.1053/j.gastro.2021.08.015

M3 - Article

C2 - 34579936

AN - SCOPUS:85115745539

SN - 0016-5085

VL - 161

SP - 1615-1627.e1

JO - Gastroenterology

JF - Gastroenterology

IS - 5

ER -

AGA Clinical Practice Guideline on the Management of Coagulation Disorders in Patients With Cirrhosis

Bibliographical note

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Cite this